Oculocare
Zürich, Switzerland
Alleye aims to prevent blindness so that people enjoy longer and healthier lives. Alleye was launched in 2015 and is a subsidiary of medignition. Alleye helps people to detect retinal diseases or to monitor the course of an existing retinal disease. The Alleye test is specialized in early detection and monitoring of age-related macular degeneration (AMD) and diabetic macular edema (DME). With the Alleye app, users can regularly test their visual performance on a mobile device. As an Alleye provider, eye doctors, opticians, and pharmacists can manage their customers and their Alleye data via alleye.io.
Only accessible to MedStartr community members.
Join nowCompany Info
- Website
- www.alleye.io/
Only accessible to MedStartr community members.
Join nowWhat do you think of Oculocare?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now